Relora® Included as Part of Flat Belly Plan
As Recognized by Nation’s Leading Health & Wellness Television Program
Salinas, California - February 7, 2013 – The nation’s leading health and wellness television program has, for the second time, featured Relora and its importance in the fight against belly fat. According to the show, this is because of the effect Relora has on lowering stress levels and the stress hormone, cortisol. Quoting a recent study, the host said that most diets will prove unsuccessful if stress reduction is not taken into consideration.
Relora is a blend of two all-natural ingredients: Magnolia officinalis bark extract and Phellodendron amurense bark extract. It has been found that Relora helps quiet the part of the brain that responds to stress (the hypothalamic-pituitary-adrenal axis) without causing drowsiness. Since its introduction, Relora has been one of the top-selling supplements in the stress relief category. Studies have demonstrated Relora to be effective in alleviating stress, curbing stress-related eating and promoting weight management.
Relora is also featured in the new book, The Thyroid Solution Diet, and will be discussed on an upcoming edition of NPR with best-selling author, Dr. Ridha Arem.
Founded in 1997, Next Pharmaceuticals provides patented, science-based natural ingredients for healthy living products in the dietary supplement, food and beverage industries. Next has successfully developed six patented and proprietary plant extracts in addition to Chromulin®, a new, safer form of the essential trace mineral chromium. Next products help consumers cope with many of today’s most prevalent and chronic health issues, significantly expanding the choices for self-care products while providing consumer brands with powerful product differentiation.
Next proprietary formulations include Relora® for stress, stress-related eating and weight management; Seditol® for improved, more restful sleep; Citri-Z® for heart health; Flavoxine® for balanced cholesterol levels; Nexrutine® for the aches and pains associated with physical activity, exercise and over-exertion; and Citrofen® for joint mobility comfort; and Chromulin® for optimum metabolism. For more information, visit www.nextpharmaceuticals.com.
Ashley Beleny / Environmental Relations PR
831-649-2334 / ashley@enviro-rel.com
Tags:
